Anders G. Holst

Biobank-driven genomic discovery yields new insight into atrial fibrillation biology

Jonas B. Nielsen, Rósa B. Þórólfsdóttir, Lars G. Fritsche et al. · Nature Genetics · 2018 · 936 citations

Life Sciences, Bioinformatics, Cardiology +14

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

Andrew Ahmann, Matthew Capehorn, G. Charpentier et al. · Diabetes Care · 2017 · 578 citations

Medicine, Pharmacology, Pharmacotherapy +16

Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial

Jesper Hastrup Svendsen, Søren Zöga Diederichsen, Søren Højberg et al. · The Lancet · 2021 · 518 citations

Medicine, Cardiology, Health Informatics +14

Risk Factors for Venous Thromboembolism

Anders G. Holst, Gorm Boje Jensen, Eva Prescott · Circulation · 2010 · 391 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +15

Nationwide study of sudden cardiac death in persons aged 1–35 years

Bo Gregers Winkel, Anders G. Holst, Juliane Theilade et al. · European Heart Journal · 2010 · 390 citations · Full text

Medicine, Cardiology, Internal Medicine +12